Point of Care Diagnostics Market: By Product Type, By Prescription Mode Testing Kits, Prescription-based Testing Kits), By End User and Region Forecast 2020-2031
Point of Care Diagnostics Market size was valued at US$ 43,741.6 million in 2024 and is expected to reach US$ 69,781.2 million by 2031, growing at a significant CAGR of 6.9% from 2025-2031. Point-of-care (POC) diagnostics are medical devices that provide immediate results in the investigation (diagnosis and monitoring) of various diseases such as diabetes, cancer, cardiac disease, and others. Based on the product, the global diagnostics market is segmented into Infectious Disease Testing Kits, Cardio-Metabolic Monitoring Kits, COVID-19 Testing Kits, Haematological Testing Kits, Fecal Occult Testing Kits, Glucose Monitoring Kits, Cholesterol Test Strips, Urinalysis Testing Kits, Others.
The Glucose Monitoring Kits segment is anticipated to grow at a significant CAGR over the forecast years, Due to increased sales of diabetes rapid diagnostics kits. These are available without a prescription over the counter and assist patients in self-testing and monitoring their glucose levels. Because the kits are widely available, they are highly preferred, increasing product sales. EKF Diagnostics, for example, announced the launch of STAT-Site WB to manage diabetes in May 2020.
The test produces results in 10 minutes and is intended for use at point-of-care diagnostics such as doctor's offices, diagnostic laboratories, and clinics. The rising prevalence of chronic and infectious diseases and a growing preference for a decentralized healthcare system are expected to drive market growth.
Study Period
2025-2031Base Year
2024CAGR
6.9%Largest Market
North-AmericaFastest Growing Market
North-America
Market Development for Point of Care Diagnostics The growing prevalence of chronic and infectious diseases in developing economies is a trend. Chronic diseases such as rheumatism, diabetes, and cancer are becoming more common worldwide for various reasons, including a rising geriatric population, sedentary lifestyles, unhealthy eating habits, and environmental factors. Chronic diseases, for example, kill almost 38 million people worldwide.
Cardiovascular illnesses account for most of the chronic disease mortality (17.5 million persons per year), followed by malignancies (8.2 million), respiratory disorders (4 million), and diabetes (1.5 million). The diseases listed above account for 82% of all chronic condition deaths. Point-of-care diagnostics is gaining popularity among patients worldwide since samples are taken from the patient's site for testing, and findings may be obtained concisely because of micro fluids, chips, and nano diagnostics.
North America will likely hold the highest revenue share in 2022, and the same trend is expected over the forecast period. Due to the presence of major market participants and the increased prevalence of infectious and chronic diseases, the area is anticipated to have considerable growth over the projected period.In addition, the region's increasing incidence of ailments including diabetes and cancer is fueling the market's expansion.
For instance, according to a report by the Canadian Diabetes Association released in March 2022, the prevalence of diabetes in the nation is rising rapidly. At the time the report was released, 11.7 million Canadians were estimated to have diabetes or prediabetes, with nearly 5.7 million of those having been diagnosed. Also, Asia Pacific held highest CAGR during forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 43,741.6 million |
|
Market Size in 2031 |
US$ 69,781.2 million |
|
Market CAGR |
6.9% |
|
By Product Type |
|
|
By Prescription Mode |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The point of care diagnostics market size was valued at US$ 43,741.6 million in 2024 and is expected to reach US$ 69,781.2 million by 2031, growing at a significant CAGR of 6.9% from 2025-2031.
Siemens-Healthineers, Abbott Laboratories, Inc., Quidel Corporation, Becton, Dickinson, and Company, bioMérieux, Roche Diagnostics, Life Scan IP Holdings, LLC, and Beckman Coulter, Inc. are the key players in the global point–of–care diagnostic market.
North America is anticipated to hold the highest market share in the market.
| 1. Executive summary |
| 2. Global Point of Care Diagnostics Market Introduction |
| 2.1. Global Point of Care Diagnostics Market – Taxonomy |
| 2.2. Global Point of Care Diagnostics Market –Definitions |
| 2.2.1. Product Type |
| 2.2.2. Prescription Mode |
| 2.2.3. End-User |
| 3. Global Point of Care Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Point of Care Diagnostics Market Dynamics – Factors Impact Analysis |
| 3.6. Global Point of Care Diagnostics Market – Regulations |
| 3.6.1. U.S. |
| 3.6.2. Europe |
| 3.6.3. Japan |
| 3.7. Global Point of Care Diagnostics Market – Recent Product Innovations |
| 4. Global Point of Care Diagnostics Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Point of Care Diagnostics Market, By Product Type, 2020 - 2024 and Forecast 2025 - 2031 |
| 5.1. Infectious Disease Testing Kits |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Cancer/Tumor Markers Testing |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Cardio-Metabolic Monitoring Kits |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Fertility and Pregnancy Testing Kits |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Hematological Testing Kits |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Fecal Occult Testing Kits |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Glucose Monitoring Kits |
| 5.7.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Cholesterol Test Strips |
| 5.8.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Urinalysis Testing Kits |
| 5.9.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 5.10. Others |
| 5.10.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.10.3. Market Opportunity Analysis |
| 6. Global Point of Care Diagnostics Market, By Prescription Mode, 2020 - 2024 and Forecast 2025 - 2031 |
| 6.1. Over-the-Counter (OTC) Testing Kits |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Prescription Based Testing Kits |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Point of Care Diagnostics Market Forecast, By End-User, 2020 - 2024 and Forecast 2025 - 2031 |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic Centers |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Homecare |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Point of Care Diagnostics Market Forecast, By Region, 2020 - 2024 and Forecast 2025 - 2031 |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Point of Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Region, 2023 & 2029 |
| 9. North America Point of Care Diagnostics Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 9.1. Product Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Infectious Disease Testing Kits |
| 9.1.2. Cancer/Tumour Markers Testing |
| 9.1.3. Cardio-Metabolic Monitoring Kits |
| 9.1.4. Fertility and Pregnancy Testing Kits |
| 9.1.5. Haematological Testing Kits |
| 9.1.6. Faecal Occult Testing Kits |
| 9.1.7. Glucose Monitoring Kits |
| 9.1.8. Cholesterol Test Strips |
| 9.1.9. Urinalysis Testing Kits |
| 9.1.10. Others |
| 9.2. Prescription Mode Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Over-the-counter (OTC) Testing Kits |
| 9.2.2. Prescription-based Testing Kits |
| 9.3. End-User Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Hospitals |
| 9.3.2. Diagnostic Centers |
| 9.3.3. Homecare |
| 9.3.4. Others |
| 9.4. Country Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. U.S. |
| 9.4.2. Canada |
| 9.5. North America Point of Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2023 & 2029 |
| 9.6. North America Point of Care Diagnostics Market Dynamics – Trends |
| 10. Europe Point of Care Diagnostics Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 10.1. Product Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Infectious Disease Testing Kits |
| 10.1.2. Cancer/Tumor Markers Testing |
| 10.1.3. Cardio-Metabolic Monitoring Kits |
| 10.1.4. Fertility and Pregnancy Testing Kits |
| 10.1.5. Hematological Testing Kits |
| 10.1.6. Fecal Occult Testing Kits |
| 10.1.7. Glucose Monitoring Kits |
| 10.1.8. Cholesterol Test Strips |
| 10.1.9. Urinalysis Testing Kits |
| 10.1.10. Others |
| 10.2. Prescription Mode Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Over-the-counter (OTC) Testing Kits |
| 10.2.2. Prescription-based Testing Kits |
| 10.3. End-User Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Hospitals |
| 10.3.2. Diagnostic Centers |
| 10.3.3. Homecare |
| 10.3.4. Others |
| 10.4. Country Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Point of Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2023 & 2029 |
| 10.6. Europe Point of Care Diagnostics Market Dynamics – Trends |
| 11. Asia-Pacific Point of Care Diagnostics Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 11.1. Product Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Infectious Disease Testing Kits |
| 11.1.2. Cancer/Tumor Markers Testing |
| 11.1.3. Cardio-Metabolic Monitoring Kits |
| 11.1.4. Fertility and Pregnancy Testing Kits |
| 11.1.5. Hematological Testing Kits |
| 11.1.6. Fecal Occult Testing Kits |
| 11.1.7. Glucose Monitoring Kits |
| 11.1.8. Cholesterol Test Strips |
| 11.1.9. Urinalysis Testing Kits |
| 11.1.10. Others |
| 11.2. Prescription Mode Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Over-the-counter (OTC) Testing Kits |
| 11.2.2. Prescription-based Testing Kits |
| 11.3. End-User Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Hospitals |
| 11.3.2. Diagnostic Centers |
| 11.3.3. Homecare |
| 11.3.4. Others |
| 11.4. Country Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), |
| Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Point of Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2023 & 2029 |
| 11.6. Asia Pacific Point of Care Diagnostics Market Dynamics – Trends |
| 12. Latin America Point of Care Diagnostics Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 12.1. Product Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Infectious Disease Testing Kits |
| 12.1.2. Cancer/Tumor Markers Testing |
| 12.1.3. Cardio-Metabolic Monitoring Kits |
| 12.1.4. Fertility and Pregnancy Testing Kits |
| 12.1.5. Hematological Testing Kits |
| 12.1.6. Fecal Occult Testing Kits |
| 12.1.7. Glucose Monitoring Kits |
| 12.1.8. Cholesterol Test Strips |
| 12.1.9. Urinalysis Testing Kits |
| 12.1.10. Others |
| 12.2. Prescription Mode Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Over-the-counter (OTC) Testing Kits |
| 12.2.2. Prescription-based Testing Kits |
| 12.3. End-User Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Hospitals |
| 12.3.2. Diagnostic Centers |
| 12.3.3. Homecare |
| 12.3.4. Others |
| 12.4. Country Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Venezuela |
| 12.4.5. Rest of Latin America |
| 12.5. Latin America Point of Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2023 & 2029 |
| 12.6. Latin America Point of Care Diagnostics Market Dynamics – Trends |
| 13. Middle East and Africa Point of Care Diagnostics Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 13.1. Product Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Infectious Disease Testing Kits |
| 13.1.2. Cancer/Tumor Markers Testing |
| 13.1.3. Cardio-Metabolic Monitoring Kits |
| 13.1.4. Fertility and Pregnancy Testing Kits |
| 13.1.5. Hematological Testing Kits |
| 13.1.6. Fecal Occult Testing Kits |
| 13.1.7. Glucose Monitoring Kits |
| 13.1.8. Cholesterol Test Strips |
| 13.1.9. Urinalysis Testing Kits |
| 13.1.10. Others |
| 13.2. Prescription Mode Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Over-the-counter (OTC) Testing Kits |
| 13.2.2. Prescription-based Testing Kits |
| 13.3. End-User Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Hospitals |
| 13.3.2. Diagnostic Centers |
| 13.3.3. Homecare |
| 13.3.4. Others |
| 13.4. Country Analysis (2018 – 2022) and Forecast (2023 & 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Point of Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2023 & 2029 |
| 13.6. MEA Point of Care Diagnostics Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Siemens-Healthineers |
| 14.2.2. Abbott Laboratories, Inc. (U.S.) |
| 14.2.3. Koninklijke Philips N.V. (Netherlands) |
| 14.2.4. Becton, Dickinson, and Company (U.S.) |
| 14.2.5. Mologic Ltd (U.K.) |
| 14.2.6. Roche Diagnostics (U.S.) |
| 14.2.7. Nova Biomedical (U.S.) |
| 14.2.8. Beckman Coulter, Inc. (U.S.) |
| 14.2.9. Ngaio Diagnostics (New Zealand) |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
